RTU-Doce RTU 80mg Injection

RTU-Doce RTU 80mg Injection contains docetaxel, an anticancer medication belonging to the taxoid class of chemotherapy drugs. It is indicated for the treatment of breast cancer, prostate cancer, non-small cell lung cancer, stomach cancer, and head and neck cancers. The medication may be used as monotherapy or in combination with other anticancer agents. Inform your doctor of any allergies to RTU-Doce RTU 80mg Injection or its ingredients. Before commencing treatment, disclose to your physician any existing kidney disease, heart problems, vision impairment, epilepsy, or alcohol dependence. The medication is not recommended for patients with severely reduced white blood cell counts or severe hepatic disease. Effective contraception must be used during treatment and for at least six months following the final dose of RTU-Doce RTU 80mg Injection. Notify your doctor of any recent vaccinations prior to initiating this treatment. Provide your healthcare provider with a complete medical history and list of current medications to ensure safe and effective use of RTU-Doce RTU 80mg Injection.

Non-small cell lung cancer Breast cancer Stomach or gastric cancer Prostate cancer Head and neck cancer

RTU-Doce RTU 80mg Injection works by binding to a protein called beta-tubulin, which helps cells grow and divide. By doing this, it stops cancer cells from dividing properly and prevents the formation of structures needed for cell division. Additionally, RTU-Doce RTU 80mg Injection reduces the activity of a gene called BCL2, which usually helps cancer cells survive. By lowering this gene's activity, the treatment helps cancer cells become more sensitive to natural cell death processes, making it easier for the body to fight against the cancer.

A healthcare professional will administer it through an intravenous infusion directly into one of your veins. Your doctor will decide the suitable dose of RTU-Doce RTU 80mg injection for you based on your weight and overall health.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Severe allergic reactions Severe fluid retention Severe skin problems Swelling of the small intestine and colon Common: Headache, dizziness Risk of infections Low blood cell count Loss of appetite Trouble sleeping Joint or muscle pain Alteration in the sense of taste Eye problems, bleeding from the nose Nausea, vomiting Diarrhea, constipation Abdominal pain Hair loss, change in color of your nails Change or absence of menstrual period Weight loss Tiredness Dry mouth High blood sugar Decreased blood pressure, rapid heartbeat

Women of reproductive age must use effective contraception during and for six months after therapy. Male patients receiving this injection treatment should avoid fathering children and use reliable contraception for six months following the treatment. A decrease in white blood cell count is the most common side effect of RTU-Doce RTU 80mg Injection. If your white blood cell count becomes low, you are at a higher risk of getting an infection. However, these levels usually return to normal before your next treatment. A blood test will be conducted before your treatment. If your white blood cell count is low, your doctor may postpone your treatment for a short period until your cell count increases. You might receive a supportive drug to stimulate your body to produce more white blood cells. Following the RTU-Doce RTU 80mg Injection infusion, you will be carefully monitored for reactions and side effects. Supportive care will help you manage and overcome these side effects. On your chemotherapy day, it is recommended that you eat lightly. Consuming small portions slowly and regularly every few hours works best. Avoid skipping meals and stay away from fatty, greasy, or spicy foods on these days. Do not hesitate to ask questions or share any concerns with your doctor.